Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
elesclomol (STA-4783)
i
Other names:
STA-4783
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(5)
News
Trials
Company:
Madrigal Pharma
Drug class:
Apoptosis stimulant, Reactive oxygen species stimulant, HSP70 stimulant
Related drugs:
‹
lurbinectedin (11)
arsenic trioxide (6)
pelareorep (4)
omacetaxine mepesuccinate (4)
GZ17-6.02 (3)
quaratusugene ozeplasmid (3)
BAL101553 (3)
teserpaturev (1)
IT-141 (1)
Alpha1H (1)
NEO100 (1)
ABI-1968 topical cream (0)
APTO-253 (0)
BP-C1 (0)
BXQ-350 (0)
CM-728 (0)
IL-17E (0)
autologous γδ T lymphocytes (0)
KLTi (0)
MT-3724 (0)
84AA-API 14AA (0)
PVT-1 (0)
SVV-001 (0)
alpha-tocopheroloxyacetic acid (0)
darinaparsin (0)
AFP-464 (0)
elemene injection (0)
BAY1862864 (0)
BS-HH-002.SA (0)
PT-112 (0)
K-333 (0)
piceatannol (0)
AP1903 (0)
PRX302 (0)
verteporfin (10)
AU-011 (1)
BOLD-100 (0)
temoporfin (0)
porfimer sodium (0)
lyso-thermosensitive liposomal doxorubicin (0)
lurbinectedin (11)
arsenic trioxide (6)
pelareorep (4)
omacetaxine mepesuccinate (4)
GZ17-6.02 (3)
quaratusugene ozeplasmid (3)
BAL101553 (3)
teserpaturev (1)
IT-141 (1)
Alpha1H (1)
NEO100 (1)
ABI-1968 topical cream (0)
APTO-253 (0)
BP-C1 (0)
BXQ-350 (0)
CM-728 (0)
IL-17E (0)
autologous γδ T lymphocytes (0)
KLTi (0)
MT-3724 (0)
84AA-API 14AA (0)
PVT-1 (0)
SVV-001 (0)
alpha-tocopheroloxyacetic acid (0)
darinaparsin (0)
AFP-464 (0)
elemene injection (0)
BAY1862864 (0)
BS-HH-002.SA (0)
PT-112 (0)
K-333 (0)
piceatannol (0)
AP1903 (0)
PRX302 (0)
verteporfin (10)
AU-011 (1)
BOLD-100 (0)
temoporfin (0)
porfimer sodium (0)
lyso-thermosensitive liposomal doxorubicin (0)
›
Associations
(5)
News
Trials
VERI cancer hierarchy
Reset Filters
GNA11 mutation
Uveal Melanoma
GNA11 mutation
Uveal Melanoma
binimetinib + STA-4783
Sensitive: D – Preclinical
binimetinib + STA-4783
Sensitive
:
D
binimetinib + STA-4783
Sensitive: D – Preclinical
binimetinib + STA-4783
Sensitive
:
D
GNAQ mutation
Uveal Melanoma
GNAQ mutation
Uveal Melanoma
binimetinib + STA-4783
Sensitive: D – Preclinical
binimetinib + STA-4783
Sensitive
:
D
binimetinib + STA-4783
Sensitive: D – Preclinical
binimetinib + STA-4783
Sensitive
:
D
GNA11 mutation
Uveal Melanoma
GNA11 mutation
Uveal Melanoma
STA-4783
Sensitive: D – Preclinical
STA-4783
Sensitive
:
D
STA-4783
Sensitive: D – Preclinical
STA-4783
Sensitive
:
D
GNAQ mutation
Uveal Melanoma
GNAQ mutation
Uveal Melanoma
STA-4783
Sensitive: D – Preclinical
STA-4783
Sensitive
:
D
STA-4783
Sensitive: D – Preclinical
STA-4783
Sensitive
:
D
MPZL3 overexpression
Breast Cancer
MPZL3 overexpression
Breast Cancer
STA-4783
Resistant: D – Preclinical
STA-4783
Resistant
:
D
STA-4783
Resistant: D – Preclinical
STA-4783
Resistant
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login